Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

AI city halls: could Robot-Run domes cure addiction and homelessness?

NCT ID NCT07661823

Disease control Sponsor: Veterans Recovery Network Inc. Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Sep 18, 2026 · Updated 10 times

Summary

This study will test whether living in a self-contained, AI-managed community (called a Microcity) can improve mental health and reduce addiction in adults with conditions like autism, ADHD, substance use disorders, and behavioral addictions. Up to 1 million participants will live in a dome-enclosed village for up to 24 months, receiving AI-driven counseling, virtual reality therapy, and other digital treatments. The goal is to see if this approach can lower costs and improve outcomes for people on fixed incomes or public assistance.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
AI-managed community with behavioral health services (AI counseling, VR therapy, attitude inoculation protocols)
What this could lead to
If it works, this could point toward a new, low-cost way to deliver mental health and addiction care using AI and self-contained communities.
What could go wrong
This is a very early, non-randomized study with no FDA-regulated drugs or devices. The approach is highly experimental, and results may not apply to broader populations. The massive enrollment goal (1 million) and complex AI system may face practical challenges.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 1,000,000 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Sep 2026

An estimate. Start dates often move.

Expected to finish

Dec 2045

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

17 to 99 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Individuals aged 17 to 99 years old. * Referral by a licensed health services professional (e.g., R.N., N.P., Ph.D., M.D.). * Referral by a non-profit organization (e.g., 501c3, university, church). * Referral by a public agency (e.g., case manager, social worker, parole/probation/PTS officer, judge). Exclusion Criteria: \* Individuals under 17 or over 99 years of age.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Abstinence, sex are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

alcohol abuse alcohol dependence atrial septal defect attention deficit hyperactivity disorder, inattentive type attention deficit-hyperactivity disorder autism autism spectrum disorder autism spectrum disorder 1 Behavior, Addictive cannabis dependence cocaine abuse Cocaine-Related Disorders Coitus Compulsive Sexual Behavior Disorder drug dependence eating disorder Gender Dysphoria hallucinogen dependence narcissistic personality disorder Narcotic-Related Disorders nicotine dependence opiate dependence opioid abuse pathological gambling physiological sexual disorder psychiatric disorder Sexual Abstinence Sexual Behavior sexual disorder Smoking substance-related disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Abstinence, sex Addiction disorders ADHD ADHD - attention deficit disorder with hyperactivity Alcohol abuse/dependence Alcohol addiction Alcohol and other drug use disorders Alcohol and other substance use prevention Anger problems ASD Asperger disorder Asperger's disorder Autism Autism disorder Child abuse, sexual Cocaine abuse Eating behavior disorders Gambling addiction Gambling disorder Gender dysphoria, adult Homeless and low incomes people, refugees Homelessness Marijuana abuse and dependence Marijuana use disorder Mdma ('ecstasy') Narcissism Narcotic addiction Narcotic-related disorders Opiate substitution treatment Opioid abuse (disorder) Opioid abuse and addiction Psychedelic drug dependence Psychedelic effects in healthy volunteers Psychedelic experiences Psychiatric disorder Reliability and validity Sex abuse Sex behavior Sex crimes Sex disorder Sex disorders Smoking (tobacco) addiction Smoking abstinence Smoking among youth

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The study's own enquiry address

    This study publishes an address for enquiries. See it below .

  2. The places running it

    1 site. The list below names each one and where it is.

  3. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  4. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

Locations

  • Administrative Office

    Richmond, Virginia, 23219, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.